Related Experiment Videos
Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents
Abstract:
Treatment of human fibroblast FS-4 cultures with human type II interferon preparations induced the synthesis of at least four proteins that were similar in size to four of the five proteins induced by type I interferons (Mr 120,000, 88,000, 67,000, and 56,000). However, the Mr 67,000 and 56,000 proteins were induced more strongly by type II than by type I interferon, and a counterpart of a Mr 80,000 protein induced by type I interferons was not noticeably induced by type II interferon preparations. We therefore compared type I and type II interferons for relative antiviral activities against different viruses (vesicular stomatitis, encephalomyocarditis, and vaccinia viruses and reovirus) and for cell growth-inhibitory activities on various cell types. The replication of vesicular stomatitis and encephalomyocarditis viruses was inhibited more strongly by type I interferon, whereas reovirus and vaccinia virus showed greater sensitivity to type II interferon preparations. This indicates that viruses may differ in their sensitivity to human type I and type II interferons and that the antiviral mechanisms induced by type I and type II interferons may have significant differences. The type I and type II interferons may have significant differences. The type I and type II interferons may also differ in their efficacies as antiproliferative agents. Type II interferon preparations at 2.5 units/ml inhibited the incorporatin of [3H]thymidine to a greater extent than did type I interferon at 400 units/ml. (For both type I and type II interferons, the unit of interferon activity was defined as the concentration that decreased the yield of vesicular stomatitis virus by 50% in FS-4 cultures.) Furthermore, whereas type II interferon preparations had a reversible cytostatic effect on normal human fibroblasts at 10 units/ml, the transformed cells tested (HeLa, osteosarcoma, U-amnion) showed extensive cell death, thus indicating that it may have a cytocidal effect on certain tumor cells. It appears that human type II interferon (or a factor present in these preparations) may be a potent antitumor agent.
Insights
Human type II interferons induce distinct protein synthesis and exhibit differential antiviral and antitumor activities compared to type I interferons, suggesting unique therapeutic potentials.
Area of Science:
- Immunology
- Virology
- Cell Biology
Background:
- Human interferons (IFNs) are crucial for antiviral defense.
- Type I and Type II IFNs are distinct classes with potentially different functions.
- Understanding their differential effects is key to optimizing therapeutic applications.
Purpose of the Study:
- To compare the protein synthesis, antiviral efficacy, and antiproliferative effects of human type I and type II interferons.
- To investigate the differential sensitivity of various viruses to type I and type II IFNs.
- To evaluate the potential antitumor activity of type II interferons.
Main Methods:
- Treatment of human fibroblast FS-4 cultures with type I and type II interferon preparations.
- Analysis of induced protein synthesis via molecular weight (Mr).
- Assessment of antiviral activity against vesicular stomatitis, encephalomyocarditis, vaccinia viruses, and reovirus.
- Evaluation of cell growth-inhibitory and cytocidal effects on normal and transformed human cell lines.
Main Results:
- Type II IFNs induced unique protein profiles, with stronger induction of Mr 67,000 and 56,000 proteins compared to Type I IFNs.
- Differential antiviral activity was observed: Type I IFNs were more potent against vesicular stomatitis and encephalomyocarditis viruses, while Type II IFNs were more effective against reovirus and vaccinia virus.
- Type II IFNs demonstrated greater antiproliferative activity and a cytocidal effect on tumor cells, unlike the reversible cytostatic effect on normal fibroblasts.
Conclusions:
- Human type I and type II interferons exhibit distinct patterns of protein induction and differential antiviral efficacies against various viruses.
- These differences suggest distinct antiviral mechanisms and varying sensitivities of viruses to each interferon type.
- Type II interferons show potent antiproliferative and potential antitumor properties, warranting further investigation as therapeutic agents.